Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection. (Q46504436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Hui Y Lan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Hai-Ying Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Amin A Nanji

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Xiao-Ru Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Chung-Mau Lo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Yong Xiong Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Siu-Tsan Yuen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

George K K Lau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

571-579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

Chronic hepatitis B virus infection: treatment strategies for the next millennium

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Expression of macrophage migration inhibitory factor in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Regulation of the CTL response by macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

Immune pathogenesis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01047.X

10.1111/J.1478-3231.2005.01047.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15910495%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference